These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3292052)

  • 1. [Approaches to testing the effects of chemical substances on the immune system].
    Procházková J
    Cas Lek Cesk; 1988 Apr; 127(14):420-5. PubMed ID: 3292052
    [No Abstract]   [Full Text] [Related]  

  • 2. The National Toxicology Program and immunological toxicology.
    Moore JA; Huff JE; Dean JH
    Pharmacol Rev; 1982 Mar; 34(1):13-6. PubMed ID: 7071122
    [No Abstract]   [Full Text] [Related]  

  • 3. Methods currently used in the pharmaceutical industry for evaluating immunotoxic effects.
    Norbury KC
    Pharmacol Rev; 1982 Mar; 34(1):131-6. PubMed ID: 7071123
    [No Abstract]   [Full Text] [Related]  

  • 4. Procedures available to examine the immunotoxicity of chemicals and drugs.
    Dean JH; Luster MI; Boorman GA; Lauer LD
    Pharmacol Rev; 1982 Mar; 34(1):137-48. PubMed ID: 6280211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational toxicology: test methods and approaches for the pharmaceutical industry.
    Sprague G; Sutton T
    Occup Med; 1997; 12(1):119-29. PubMed ID: 9153057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopharmacology and its toxicological problems.
    Sterzl J
    Arch Toxicol Suppl; 1980; 4():109-19. PubMed ID: 6159870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological aspects of toxicology. Chicago, Illinois, May 17-20, 1981.
    Pharmacol Rev; 1982 Mar; 34(1):1-151. PubMed ID: 7071121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of mathematical theory in the experiments for the evaluation of the combined effects of chemical substances].
    Sova RE
    Gig Sanit; 1984 Jan; (1):39-41. PubMed ID: 6706155
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indices of the immune system and the activity of NADPH-dependent dehydrogenases in the lymphocytes in patients in prolonged contact with radioactive and chemical substances].
    Savchenko AA; Borisov AG
    Gig Sanit; 1993 Dec; (12):20-2. PubMed ID: 8125359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological aspects of toxicology: premises not promises.
    Yoshida S; Golub MS; Gershwin ME
    Regul Toxicol Pharmacol; 1989 Feb; 9(1):56-80. PubMed ID: 2667038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxicology.
    Descotes G; Mazué G
    Adv Vet Sci Comp Med; 1987; 31():95-119. PubMed ID: 3300206
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity assessment of unintentional exposure to multiple chemicals.
    Mumtaz MM; Ruiz P; De Rosa CT
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):104-13. PubMed ID: 17599373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance.
    Germolec DR
    Toxicol Lett; 2004 Apr; 149(1-3):109-14. PubMed ID: 15093255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity testing, hazard assessment and data quality assurance for chemical regulatory purposes.
    Noel PR
    Dev Toxicol Environ Sci; 1980; 8():453-63. PubMed ID: 7308045
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender-based differences in endocrine and reproductive toxicity.
    Cummings AM; Stoker T; Kavlock RJ
    Environ Res; 2007 May; 104(1):96-107. PubMed ID: 17157289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential role of hormesis in risk assessment in occupational toxicology].
    Iavicoli I; Carelli G
    G Ital Med Lav Ergon; 2003; 25 Suppl(3):174-5. PubMed ID: 14979136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The basic methodological approaches to testing the teratogenic activity of chemical substances].
    Dyban AP; Baranov VS; Akimova IM
    Arkh Anat Gistol Embriol; 1970; 59(10):89-100. PubMed ID: 5511190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.